The treatment of Cancer Risk Reduction & Hay Fever with vitamins

Cancer Risk Reduction and Hay Fever: Mitamins custom make quality formulas for the treatment of Cancer Risk Reduction & Hay Fever with vitamins. A Cancer Risk Reduction & Hay Fever formula will be made to suit you, using quality brand name ingredients. Mitamins produce custom made vitamin and supplement formulas to suit your individual health needs conveniently in one formula, one bottle and one dosage. For assistance, call toll free: 1-866-585-1390
Your Supplements Facts - Covers the formulas above
Supplement Facts

Specially Formulated for: Cancer Risk Reduction and Hay Fever

  • Amount Per Serving
    % DV
    Vitamin A
    2500
    IU
    50%
    Vitamin C
    100
    mg
    167%
    Vitamin E
    100
    IU
    333%
    Magnesium
    50
    mg
    13%
    Zinc
    10
    mg
    67%
    CoQ-10
    15
    mg
    *
    Ginkgo Extract
    40
    mg
    *
  • Amount Per Serving
    % DV
    Grape Seed Extract
    50
    mg
    *
    Green Tea Extract
    50
    mg
    *
    Licorice Extract
    100
    mg
    *
    Quercetin
    100
    mg
    *
    L-Glutathione Reduced
    100
    mg
    *
    * Daily Value (DV) not established
Name Your Supplement Bottle - Just how you like it
The current default name is: 
 
(Click in box to change)
Your Perfect Supplement - Custom-made just for you
Formulas form 35 Years of Medical Practice
Cancer Risk Reduction and Hay Fever
Monthly Cost: $28.34
Serving Size:4-5
30 Days Money Back Guarantee
100% Satisfaction Guarantee

Cancer Risk Reduction and Hay Fever Formulas Details

Customize Your Supplements - Check all that apply
4A Select additional condition(s) you want to address:


4B Select all the medication(s) you are taking:
Update This Formula
If your concern or medication is not listed here, use our Formulator, which covers 680 concerns and 1600 drugs, Click here!
Latest Health Related News:
Tysabri Approved By NICE, UK
The MS Society has welcomed the decision, which will benefit nearly 3,000 people with this form of MS.Simon Gillespie, chief executive of the MS Society, said: "We welcome confirmation of NICE's decision to approve Tysabri, which represents a vital treatment option for people with highly active relapsing remitting MS."The health trusts now have three months to make Tysabri available and we hope there are no unnecessary delays.
Coming Soon: Pain-Free Dentistry (HealthDay)
The phrase "no pain, no gain" may someday not apply to the dentist's office, according to a team developing a drill-free cavity treatment.
This information concerning the support of Cancer Risk Reduction and Hay Fever treatments provide basic knowledge which should always be discussed with your own health practitioner.
Any Questions, Call Us Toll Free: 1-866-585-1390
Mitamins Logo
Home  Multi-Conditions formulas  Cancer & Chemo  Cancer Risk Reduction  Cancer Risk Reduction and Hay Fever
Live Chat System

manufactured In USA

  verisign          Trust E Finalmark

Custom Vitamins and Nutritional Supplements for Supporting Age-Related Cognitive Decline and Aging Treatments